Cite

HARVARD Citation

    Oh, S. et al. (2016). Amifampridine phosphate (Firdapse®) is effective and safe in a phase 3 clinical trial in LEMS. Muscle & nerve. 53 (5), pp. 717-725. [Online]. 
  
Back to record